Biotechnology Market Revenue to Attain USD 5.03 Bn by 2033

09 Sep 2025

Share :

Table of Content

1. Biotechnology Market Revenue and Trends 2025 to 2033 2. Biotechnology Market Growth Factors 3. Biotechnology Market Coverage 4. Report Highlights 5. Regional Insights

Biotechnology Market Revenue and Trends 2025 to 2033

The global biotechnology market revenue reached USD 1.77 billion in 2025 and is predicted to attain around USD 5.03 billion by 2033 with a CAGR of 13.90%.

Biotechnology Market Growth Factors

The growing government initiatives and support to promote the growth of the biotechnology industry is the major driving force of the global biotechnology market. The modernization of the regulatory pathways, boosting up the approval processes, standardization of the clinical studies, and the development of favorable reimbursement policies are several significant initiatives that has exponentially propelled the growth of the global biotechnology market. The surging demand for the personalized and orphan drugs across the globe is expected to augment the demand for the biotechnology drugs in the forthcoming period.

The growing prevalence of various chronic diseases has fostered the adoption of biotech in the drug discovery and development. The rising adoption of the biotechnology in the various end use verticals such as pharmaceuticals, industries, informatics, and agriculture is further fueling the growth of the biotechnology market across the globe.

Biotechnology Market Coverage

Report Highlights

• Based on the application, the global biotechnology market was dominated by the bio-pharmacy segment in 2021. The emergence of several biotechnology drugs that are efficient at curing several chronic diseases like cancer which were previously non-curable has gained a rapid traction across the globe. The rising investments in the research and development for drug discovery for the treatment of numerous gene related diseases and other chronic diseases is expected to ensure the dominance of the bio-pharmacy segment throughout the forecast period.
• On the basis of technology, the nano-biotechnology was the dominant segment in 2021. This growth is attributed to the increased technological advancements in the nanotechnology field. Moreover, the rising investments in the integration of novel technologies like artificial intelligence (AI) and cloud computing that facilitates fast and accurate RNA/DNA sequencing is significantly driving the growth of the nano-biotechnology segment across the globe.
• By application: the DNA sequencing segment led the market in 2024 due to the increasing integration of advanced DNA sequencing techniques. In this segment, the nanobiotechnology segment is expected to grow fastest during the forecast period, driven by the increasing approvals of nanomedicine.
• By technology: the marijuana buds segment contributed to the largest market revenue in 2024, driven by the increasing acceptance of cannabis in society. In this segment, the chromatography segment is expected to grow fastest during the forecast period, due to the increasing techniques that offer unparalleled analytical precision.

Regional Insights

How North America Dominates the Biotechnology Market Revenue in 2024?

North America dominated the market revenue in 2024. The market growth in the region is attributed to the factors such as the increasing adoption of personalized medicine applications, increasing prevalence of chronic diseases, rising R&D
activities and increasing presence of market key players. The U.S. and Canada are dominating countries driving the market growth.

Region wise, North America was the leading biotechnology market in 2021. The government in the developed market like US has played a crucial role in the exponential growth of the biotechnology industry by introducing new regulations, compliances, and policies pertaining to the biotechnology. The presence of numerous biotechnology companies and the impressive investments by them in the research and development activities is fueling the market growth. Furthermore, there is a huge demand for the biotechnology medicines in US owing to the increased prevalence of various diseases such as diabetes, cancer, cardiovascular diseases, and respiratory diseases among the population. The availability of favorable reimbursement policies in the region has significantly contributed towards augmenting the demand for the biotechnology medicines in the region, which has ultimately led to the dominance of North America in the global biotechnology market.

Asia Pacific Biotechnology Market Trends

Asia Pacific is expected to grow fastest during the forecast period. The market growth in the region is driven by factors such as expansion of strategies from key players, increasing favorable government initiatives and rising improvement and investments in healthcare infrastructure. China, India, Japan and South Korea are the fastest growing countries driving the market growth.

Asia Pacific is witnessing the fastest growth rate during the forecast period. The rising FDIs of top biotechnology MNCs in the region owing to the cheap availability of various factors of production and favorable government policies is fueling the growth of the Asia Pacific biotechnology market. The surging adoption of the biotechnology in the pharmaceutical and agriculture industries is significantly fostering the market growth in the region.

Future of Biotechnology Market

The advent of the novel technologies in the biotechnology is expected to accelerate the market growth. The technologies such as 3D bioprinting and biosensors are getting a rapid traction in the life sciences and the healthcare sector across the globe. The rising usage of these technologies in the development of medicines and diagnosis is anticipated to have a significant impact on the growth of the biotechnology market.

Recent Developments

• In August 2025, an initiative to give fillip to bio-resources enterprise and startups, the Odisha Marine Biotechnology Research and Innovation Corridor (OMBRIC) was launched by Chief Minister Mohan Charan Majhi.
• In March 2025, Union Minister of State for Science and Technology, Dr Jitendra Singh, today highlighted that there are around 10,000 biotechnology startups in India, contributing to an estimated 165 billion dollar bioeconomy.
• In September 2020, F. Hoffmann-La Roche Ltd. acquired an Irish biotechnology company named Inflazome, which was engaged in developing inflammasome inhibitors.
• In September 2019, Bayer AG entered into an merger agreement of US$ 63 billion with Monsanto India for the formation of the Bayer CropScience Ltd.
• In April 2021, the Thermo Fischer Scientific acquired a clinical research organization.

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/1450

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com |+1 804 441 9344